Who are Orikine Bio's investors?

Orikine Bio's investors include AdBio partners, Asabys Partners.

Where is Orikine Bio headquartered?

Orikine Bio is headquartered in Barcelona, ES.

Orikine Bio

Barcelona, ES · Founded 2022 · 18 employees on LinkedIn · 2 known investors

Find your way into Orikine Bio

Paths you didn't know you had: your email and LinkedIn already hold routes to the Orikine Bio team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Orikine Bio develops engineered cytokines called Foldikines™ to reprogram immune responses for treating autoimmune and inflammatory diseases. The platform uses bi-specific cytokines designed to target specific immune cells with precision while minimizing off-target toxicities.

Biotech Deep Tech Healthtech Medical Devices

Founders & leadership

Orikine Bio was founded in 2022 by Ariadna Montero, Alejo Chorny, Prof. Luis Serrano, and Dr. Javier Delgado.

Ariadna Montero Scientific Founder, Head of Innovation Management & Corp. Comm.Ariadna Montero holds a PhD in Biomedicine and an Executive MBA, with experience leading digital R&D initiatives in pharmaceutical drug design and product development. She is Scientific Founder and Head of Innovation Management & Corporate Communications at Orikine Bio.

Alejo Chorny Co-founder & Former-CEOAlejo Chorny co-founded Orikine Bio and served as CEO, building the company's pipeline around engineered cytokines for immune modulation; he previously held roles as operating partner at AdBio Partners and in business development and external innovation at BIAL Pharmaceuticals, with over 20 years of experience across academia, biotech, pharma, and venture capital.

Prof. Luis SerranoScientific Founder, Advisor

Dr. Javier DelgadoScientific Founder, Advisor

Christian Pangratz CEO & Board DirectorChristian Pangratz held senior leadership roles at multiple biotechnology and pharmaceutical companies including Nektar Therapeutics, Pfizer, Bayer, and Vectura Group, and served on boards of companies operating in pharmaceuticals and diagnostics across Switzerland, China, and Europe. He brings expertise in product management, business development, corporate strategy, and respiratory and immunological therapeutic areas.

Board

Larry EdwardsChairman of the Board

Investors · 2

AdBio partnerslisted by AdBio partnersParis

How we know: AdBio partners's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us

Asabys Partnerslisted by Asabys PartnersBarcelona

How we know: Asabys Partners's portfolio page · a partner's Signal profile · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us

Frequently asked questions

What does Orikine Bio do?: Orikine Bio develops engineered cytokines called Foldikines™ to reprogram immune responses for treating autoimmune and inflammatory diseases. The platform uses bi-specific cytokines designed to target specific immune cells with precision while minimizing off-target toxicities.
Who founded Orikine Bio?: Orikine Bio was founded by Ariadna Montero, Alejo Chorny, Prof. Luis Serrano, Dr. Javier Delgado in 2022.
Who are Orikine Bio's investors?: Orikine Bio's investors include AdBio partners, Asabys Partners.
Where is Orikine Bio headquartered?: Orikine Bio is headquartered in Barcelona, ES.